Close Menu

NEW YORK (GenomeWeb) – Clinical genomic testing company Variantyx has received a $7 million investment from Israeli firm Pitango Venture Capital.

Pitango, based in Herzliya, said today that the funding round is part of its new Pitango HealthTech Fund, which the firm aims to close at $150 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.